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Abstract
Background:  Extreme pathways (ExPas) have been shown to be valuable for studying the
functions and capabilities of metabolic networks through characterization of the null space of the
stoichiometric matrix (S). Singular value decomposition (SVD) of the ExPa matrix P has previously
been used to characterize the metabolic regulatory problem in the human red blood cell (hRBC)
from a network perspective. The calculation of ExPas is NP-hard, and for genome-scale networks
the computation of ExPas has proven to be infeasible. Therefore an alternative approach is needed
to reveal regulatory properties of steady state solution spaces of genome-scale stoichiometric
matrices.
Results: We show that the SVD of a matrix (W) formed of random samples from the steady-state
solution space of the hRBC metabolic network gives similar insights into the regulatory properties
of the network as was obtained with SVD of P. This new approach has two main advantages. First,
it works with a direct representation of the shape of the metabolic solution space without the
confounding factor of a non-uniform distribution of the extreme pathways and second, the SVD
procedure can be applied to a very large number of samples, such as will be produced from
genome-scale networks.
Conclusion: These results show that we are now in a position to study the network aspects of
the regulatory problem in genome-scale metabolic networks through the use of random sampling.
Contact: palsson@ucsd.edu
Background
In recent years, chemically-detailed metabolic networks
capable of simulating growth have been reconstructed at
the genome-scale for nearly twenty organisms [1]. Any
metabolic network can be represented as a stoichiometric
matrix, and by assuming steady-state conditions one can
compute the "space" in which all allowable steady-state
flux distributions reside. This space can be spanned by a
set of extreme pathways (ExPas) [2,3], and for a given met-
abolic network this set is unique, invariant and irreducible
[4]. ExPas are so named because they form the edges of the
steady-state solution space of the network and thus char-
acterize its "extreme" functions. Mathematically, the
ExPas are a set of conical basis vectors that forms a convex
cone in high-dimensional space. In this manner, the
extreme pathways circumscribe all of the possible steady-
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state flux distributions possible in the metabolic network.
Biochemically, each ExPa corresponds to a steady-state
flux distribution through the network, and is more than
just a linear set of reactions linking substrate to product.
Specifically, each ExPa describes the relative fluxes among
a set of reactions needed for the conversion of substrate(s)
into product(s), and does so by creating all byproducts
needed to maintain systemic balances and by simultane-
ously maintaining all cofactor pools at steady state. The
development of such network-based pathway definitions,
including the elementary flux modes [5-7], has led to a
systems view of network properties [8]. Genome-scale
metabolic pathway analysis [5,9,10] holds much promise
for understanding fundamental aspects of network func-
tionality, robustness, and regulation [11,12], for meta-
bolic engineering [13,14], and for elucidating many other
systems properties [12,15-23].
The number of ExPas for a reaction network grows expo-
nentially with network size, limiting their use for the anal-
ysis of large networks. Because of this limitation, ExPas
have mainly been used to analyze realistic, but small, net-
works such as the hRBC [22]. In further work [4,24], sin-
gular value decomposition (SVD) was applied to the ExPa
matrices (P), resulting in two key insights. First, it was
shown that SVD of P can compute the effective dimen-
sionality of the regulatory problem from a network per-
spective. Second, it was shown that the 'eigenpathways'
that correspond to the modes of the SVD identified key
network branch points that can represent key control
points (reactions) in the network. These points constitute
a minimal set of reactions whose control sets the steady
state flux state for the entire network, represented as a spe-
cific location in the steady-state solution space. SVD rank
orders these key branch points in accordance with the
shape of the solution space and thus rank orders the effec-
tiveness by which the branch points can be used to move
the network's flux distribution around in the solution
space. These features were demonstrated by showing that
the dominant features of the first five eigenpathways cor-
respond to actual major points of control in the hRBC and
can effectively locate the solution in a 5-dimensional
space [24]. SVD of P can thus define the magnitude and
nature of the regulatory problem associated with control-
ling a metabolic network.
Given the fundamental understanding of network proper-
ties that can be derived from the SVD of P, it would be nat-
ural to perform the same analysis on the much larger
genome-scale metabolic networks that have already been
reconstructed. Unfortunately, this is not currently possi-
ble due to the NP-hard nature of calculating ExPas. Even
if computing ExPas were possible on a genome-scale, the
likely result would be matrices containing extremely large
numbers of ExPas, many more than would be needed
using uniform random sampling. This number of ExPas
presents an additional formidable hurdle for the SVD cal-
culation, which is an O(n2) algorithm [25].
In this work, we demonstrate an approach that addresses
this problem. As mentioned above, the set of ExPas for a
metabolic network defines the shape of the steady-state
solution space of the network. The information that SVD
of the set of ExPas provides is a description of the space.
The eigenvectors that are produced by the SVD indicate, in
rank order, the directions corresponding to the greatest
variance in the high-dimensional space, and the singular
values give the relative magnitude of this variation. A
potentially better approach is to characterize the shape of
the solution spaces by generating uniform random sam-
ples within it. Each sample solution is used as a column in
a matrix (W). With enough samples, a "picture" of the
solution space emerges, which can then be analyzed using
SVD in the same manner as was done previously for the
ExPas. In this work, we performed uniform random sam-
pling of the steady-state solution space of the hRBC meta-
bolic network and applied SVD to the matrix, W, of these
samples. We show that similar, though not identical,
results are obtained through SVD of W as were obtained
through SVD of P. Thus, this study provides a new method
for the calculation of Principle Regulatory Modes (PRMs)
that improves upon the previous method by being more
tractable for genome-scale networks due to its independ-
ence from ExPas. Additionally, the interpretation of the
results of the new method are more straightforward
because it characterizes the shape of the solution space
uniformly, without being affected by the non-uniformity
of the distribution of ExPas on the edges of the solution
space.
Results
Ascertaining sampling sufficiency
We first determined that the steady-state solution space of
the hRBC was thoroughly sampled and that an accurate
set of solutions had been sampled. Incomplete sampling
would have the effect of misrepresenting the shape of the
space and would lead to inaccurate results. We deter-
mined the thoroughness of the sampling by plotting the
angle (see Methods section) between subsequent SVD
modes for increasing sample sizes. This convergence is
shown in Figure 1 for the five modes with the largest sin-
gular values. As can be seen, convergence occurred after
using just a few thousand sample solutions, with very lit-
tle change over the remainder of the one million samples.
This result demonstrates that the solution space of a small
metabolic network, which in the hRBC contains just 51
reactions, can be studied with relatively few samples.BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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Comparing the modes derived from P and W
The modes corresponding to the first five singular values
obtained from SVD of the extreme pathways (eigenpath-
ways) and from the samples (principal regulatory modes,
or PRMs) were shown on a flux map of the hRBC. These
maps were then compared by placing them side-by-side in
Figures 2, 3, 4, 5, 6. The differences and similarities
between the eigenpathways and PRMs are addressed in
the Discussion section.
Assessing the correspondence of inferred reaction 
regulatory importance
One of the primary insights resulting from the application
of SVD to P was an understanding of the relative impor-
tance amongst all of the reactions in terms of regulatory
control. The aim of this work was to show that similar
insight can be obtained through uniform random sam-
pling. To do this, we followed a previously developed pro-
cedure [26] and scored each reaction by the l2-norm
(length) of its loading vector, which is a vector of the reac-
tion's contribution to each of the eigenvectors resulting
from the SVD procedure (see Methods section). The
rationale for this scoring method is based on our goal of
identifying those reactions most critical for controlling
flux through the metabolic network. These control reac-
tions are expected to have larger contributions to the
eigenvectors resulting from the SVD procedure. The
impact of these larger contributions is reflected in a larger
absolute value of the loading vector, signifying a larger
distance of the reaction from the origin. So in this context
the l2-norm quantifying the length of the loading vector is
appropriate for our purposes.
The SVD procedure was applied for increasingly larger sample sizes (up to 1,000,000 in increments of 2,000) and the first five  modes at each sample size were recorded Figure 1
The SVD procedure was applied for increasingly larger sample sizes (up to 1,000,000 in increments of 2,000) and the first five 
modes at each sample size were recorded. These plots show the convergence of the angle between the modes for subsequent 
sample sizes.BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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The first eigenpathway derived from SVD of the extreme pathways matrix and the first PRM derived from SVD of the samples  matrix for the hRBC metabolic network Figure 2
The first eigenpathway derived from SVD of the extreme pathways matrix and the first PRM derived from SVD of the samples 
matrix for the hRBC metabolic network. The relative values of the flux values is indicated by the thickness of the arrows 
between metabolites. The metabolite and reaction definitions are given in Table 1 and Table 2.BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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The second eigenpathway derived from SVD of the extreme pathways matrix and the second PRM derived from SVD of the  samples matrix for the hRBC metabolic network Figure 3
The second eigenpathway derived from SVD of the extreme pathways matrix and the second PRM derived from SVD of the 
samples matrix for the hRBC metabolic network. The relative values of the flux values is indicated by the thickness of the 
arrows between metabolites. The metabolite and reaction definitions are given in Table 1 and Table 2.BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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The third eigenpathway derived from SVD of the extreme pathways matrix and the third PRM derived from SVD of the sam- ples matrix for the hRBC metabolic network Figure 4
The third eigenpathway derived from SVD of the extreme pathways matrix and the third PRM derived from SVD of the sam-
ples matrix for the hRBC metabolic network. The relative values of the flux values is indicated by the thickness of the arrows 
between metabolites. The metabolite and reaction definitions are given in Table 1 and Table 2.BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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The fourth eigenpathway derived from SVD of the extreme pathways matrix and the fourth PRM derived from SVD of the  samples matrix for the hRBC metabolic network Figure 5
The fourth eigenpathway derived from SVD of the extreme pathways matrix and the fourth PRM derived from SVD of the 
samples matrix for the hRBC metabolic network. The relative values of the flux values is indicated by the thickness of the 
arrows between metabolites. The metabolite and reaction definitions are given in Table 1 and Table 2.BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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The fifth eigenpathway derived from SVD of the extreme pathways matrix and the fifth PRM derived from SVD of the samples  matrix for the hRBC metabolic network Figure 6
The fifth eigenpathway derived from SVD of the extreme pathways matrix and the fifth PRM derived from SVD of the samples 
matrix for the hRBC metabolic network. The relative values of the flux values is indicated by the thickness of the arrows 
between metabolites. The metabolite and reaction definitions are given in Table 1 and Table 2.BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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Scores allow us to impart a rank ordering on the reactions.
The degree to which the SVD of W and the SVD of P pro-
vide similar information about the regulatory importance
of the reactions, then, is measured by the similarity in
which they rank order the reactions by their scores. We
measured this similarity by computing the rank correla-
tion coefficient between the two rank orderings of reac-
tions. Just like Pearson's correlation coefficient, the rank
correlation has a range [-1, 1]. We used two related rank
correlation measures [27]: Kendall's tau and Spearman's
rho. We found the reaction rankings to be highly corre-
lated, resulting in a tau value of 0.88 with P-value 1.1*10-
15 and a rho value of 0.97 with P-value 4.0*10-12. Based on
these results, we claim that the sampling methodology
produces similar insight into identifying the most impor-
tant reactions for flux control as did the ExPa-based
approach.
Reconstruction of physiological flux distributions
We determined how the modes computed from SVD of W
were combined to reconstruct the physiological flux distri-
butions and how the difference between the reconstructed
and actual distributions diminished as more singular
modes were used to reconstruct the desired solution. The
reconstruction and difference computations were per-
formed in the same manner as described previously
(Price, Reed et al. 2003). Additionally, we assessed how
the efficiency of these reconstructions compared with
those based on the eigenpathways. The results are shown
in Figure 7. These results indicate that in 3 out of the 4
cases, fewer of the PRMs are required for reconstructing
the flux distributions than were required using eigenpath-
ways. In the fourth case, the same number of modes yields
similar reconstruction accuracy.
A comparison of how the eignpathways and PRMs reconstruct four different physiological flux distributions in the hRBC Figure 7
A comparison of how the eignpathways and PRMs reconstruct four different physiological flux distributions in the hRBC. The 
upper plots show the mode weightings for reconstructing the flux distributions, and the lower plots show the relative error 
between the reconstructed and physiological flux distributions for increasing numbers of modes.BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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Genome-scale sampling
While the sampling approach detailed herein used the
hRBC for demonstration purposes, the intended applica-
tion for the method is genome-scale metabolic networks.
A requirement for application to such networks is the
demonstration of sufficient sampling of their much
higher-dimensional steady-state solution spaces. In this
section we demonstrate that sufficient sampling is feasible
on the genome scale, in the same manner as was done for
the hRBC in the Results section above. We use the bacte-
rium  Helicobacter pylori metabolic reconstruction [28],
which is composed of 341 metabolic genes catalyzing 554
reactions amongst 485 metabolites. As can be seen in Fig-
ure 8, satisfactory convergence is obtained for the first five
modes after 150,000 samples.
Discussion
In previous work [24] it was demonstrated that SVD of the
extreme pathway matrix for the hRBC metabolic network
revealed the essential dimensionality of the regulatory
problem. Furthermore, it was shown that the dominant
features of the eigenpathways corresponding to the five
largest singular values corresponded to control points in
the hRBC metabolic network. These results are significant
because they demonstrate a potentially powerful method
for developing network-based understanding of regula-
tion in genome-scale metabolic networks. Unfortunately,
the method relies on the computation of the extreme
pathways for these networks – a computational exercise
that is currently infeasible. In an effort to circumvent this
obstacle, we investigated the utility of randomly sampling
The SVD procedure was applied for increasingly larger sample sizes (up to 200,000 in increments of 10,000) for the metabolic  network of the bacterium Helicobacter pylori and the first five modes at each sample size were recorded Figure 8
The SVD procedure was applied for increasingly larger sample sizes (up to 200,000 in increments of 10,000) for the metabolic 
network of the bacterium Helicobacter pylori and the first five modes at each sample size were recorded. These plots show the 
convergence of the angle between the modes for subsequent sample sizes.BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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the steady-state solution space of the hRBC metabolic net-
work, and through SVD of the matrix of sampled solution
points arrived at comparable results to those obtained via
SVD of P. We present three main results. First, we found
that the sampling procedure did lead to the same esti-
mates of the dimensionality of the regulatory problem for
the metabolic network studied. Secondly, we demon-
strated that the resulting PRMs reconstruct physiological
flux distributions as efficiently as did the eigenpathways.
Thirdly, we showed that the flux adjustments represented
by the PRMs were similar, and similarly interpretable, as
those represented by the eigenpathways. In particular, we
found that the ranking of reactions by their regulatory
"importance" in the two approaches was highly correlated
with high statistical significance.
It is important to note that there is no a priori reason for
believing that SVD of P would be superior to SVD of W.
Thus, while the focus of this work was to explain the
results of SVD of W in the context of what had already
been shown for SVD of P, it is not necessary that an effort
be made to force SVD of W  to reproduce SVD of P.
Instead, what was shown herein is that the approaches can
be thought of as attacking the same problem and that SVD
of W provides a way forward into genome-scale matrices
to the line of inquiry that was begun with SVD of P, since
sampling of genome-scale metabolic states has been
accomplished at the genome-scale for E. coli and H. pylori
[29,30] – whereas the computation of P for these net-
works has proven infeasible. The results of the two meth-
ods will not generally be identical. In the case of SVD of P
not only the shape of the space, but, more precisely, the
distribution of the pathways along the edges of the space
is what is being characterized. Because the samples are
generated uniformly in the solution space, it is the shape
of the solution space alone that is being characterized in
this approach. Thus, the interpretation of SVD of W is
more straightforward than is the interpretation of SVD of
P.
We used physiological flux distributions computed from
a kinetic model and compared how well PRMs and eigen-
pathways reconstructed them. As can be seen in Figure 7,
the PRMs performed just as well, if not better, than the
eigenpathways. Indeed, in three instances, the PRMs
arrived at essentially complete reconstructions utilizing
fewer PRMs. Based on these results, we estimate the regu-
latory problem for the hRBC to be roughly five-dimen-
sional – in agreement with the estimate based on the
eigenpathways.
We compared the PRM and eigenpathway flux distribu-
tions in two ways. Figures 2, 3, 4, 5, 6 utilize a flux map of
the hRBC and are graphical in manner. Table 3 offers a
more concise comparison in that it quantifies the projec-
tions of the PRMs and eigenpathways onto one another.
In comparing the first five flux maps for the PRMs and
eigenpathway fluxes directly we found the first two PRMs
and eigenpathways have similar flux distributions (Fig-
ures 2 and 3 and Table 3). In the remaining three cases
(Figures 4, 5, 6), though, the flux distributions diverge. It
can be seen, especially in Table 3, that eigenpathway 3 is
more similar to PRM 4 than PRM3, eigenpathway 4 is
most similar to PRM 5, and eigenpathway 5 is almost
exactly between PRMs 4 and 5. The reason for the diver-
gence of modes is likely due to non-uniform densities of
ExPas in the solution space, which since the SVD is a least
squares method would have more variation in certain
regions than presumably would a randomly sampled
space.
The flux maps in Figures 2, 3, 4, 5, 6 demonstrate addi-
tional satisfying correspondence between PRMs and
eigenpathways. First, the principal singular mode (first
Table 1: Metabolite abbreviations used in Figures 2–6.
Abbr. Metabolite Abbr. Metabolite
13DPG 1,3-diphosphoglycerate GLU glucose
23DPG 2,3-diphosphoglycerate HX hypoxanthine
2PG 2-phosphoglycerate IMP inosine monophosphate
3PG 3-phosphoglycerate INO inosine
6PGC phosphogluconate LAC lactate
6PGL phosphogluco-lactone PEP phosphenolpyruvate
ADE Adenine Pi inorganic phosphate
ADO Adenosine PRPP 5-phosphoribosyl-1-pyrophosphate
DHAP dihydroxyacetone phosphate PYR pyruvate
E4P erythrose-4-phosphate R1P ribose-1-phosphate
F6P fructose-6-phosphate R5P ribose-5-phosphate
FDP fructose-1,6-bisphosphate RL5P ribulose-5-phosphate
G6P glucose-6-phosphate S7P sedoheptulose-7-phosphate
GA3P glyceraldehyde-3-phosphate X5P xylulose-5-phosphateBMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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PRM) is a valid flux distribution, adhering to mass bal-
ance and thermodynamic constraints just as is the case
with the principal eigenpathway. Second, the regulatory
correspondence that was achieved with the eigenpathways
is also possible with the PRMs. For example, the domi-
nant feature of the second PRM is also the flux split
between glycolysis and the pentose phosphate pathway.
The third singular mode describes, similarly to the third
eigenpathway, the glycolytic pathway with the production
of ATP, but instead of proceeding through to pyruvate
with the production of NADH, it proceeds through to lac-
tate with the utilization of NADH to produce NAD. The
fourth PRM, as can be seen in Figure 5, is closer to eigen-
pathway 5, and this is due to the dominant feature of
pyruvate uptake and subsequent conversion to lactate.
Finally, the fifth PRM shares the same dominant charac-
terization as eigenpathway 4, this being the flux split
between lower glycolysis and the Rapoport-Luebering
shunt.
The PRMs of W  have a slightly different interpretation
than the eigenpathways derived from P. Mathematically,
the modes of W are the orthogonal directions of maximal
variance in the steady-state solution space of the stoichio-
metric matrix. Biochemically, they correspond to the
directions of greatest flexibility in achieving a network-
wide flux distribution. The unequal variances in these
orthogonal directions imply a hierarchy, wherein control
of the more dominant modes gives the cell more control
of achieving a desired flux distribution.
Conclusion
From these results we conclude that SVD of a sample of
uniformly obtained steady state flux distributions for a
metabolic network leads to a similar means of character-
izing the regulatory problem as was obtained previously
with ExPas. This was a necessary demonstration on a
small system, before applying the technique to genome-
scale networks. With a number of genome-scale metabolic
Table 2: Reaction abbreviations used in Figures 2–6. The corresponding reaction stoichiometries are also included.
Abbr. Enzyme Name Metabolic Reaction
ADA Adenosine deaminase ADO + H2O → INO + NH3
AdPRT Adenine phosphoribosyl transferase PRPP + ADE + H2O → AMP + 2 Pi
AK Adenosine kinase ADO + ATP → ADP + AMP
ALD Aldolase FDP ↔ GA3P + DHAP
AMPase Adenosine monophosphate phosphohydrolase AMP + H2O → ADO + Pi + H
AMPDA Adenosine monophosphate deaminase AMP + H2O → IMP + NH3
ApK Adenylate Kinase 2 ADP ↔ ATP + AMP
DPGase Diphosphoglycerate phosphatase 23DPG + H2O → 3PG + Pi
DPGM Diphosphoglyceromutase 13DPG → 23DPG + H
EN Enolase 2PG ↔ PEP + H2O
G6PDH Glucose-6-phosphate dehydrogenase G6P + NADP → 6PGL + NADPH + H
GAPDH Glyceraldehyde phosphate dehydrogenase GA3P + NAD + Pi ↔ 13DPG + NADH + H
HGPRT Hypoxanthine guanine phosphoryl transferase PRPP + HX + H2O → IMP + 2 Pi
HK Hexokinase GLU + ATP → G6P + ADP + H
IMPase Inosine monophosphatase IMP + H2O → INO + Pi + H
LD Lactate dehydrogenase PYR + NADH + H ↔ LAC + NAD
PDGH 6-phosphoglycononate dehydrogenase 6PGC + NADP → RL5P + NADPH + CO2
PFK Phosphofructokinase F6P + ATP → FDP + ADP + H
PGI Phosphoglucoisomerase G6P ↔ F6P
PGK Phosphoglycerate kinase 13DPG + ADP ↔ 3PG + ATP
PGL 6-phosphoglyconolactonase 6PGL + H2O ↔ 6PGC + H
PGM Phosphoglyceromutase 3PG ↔ 2PG
PK Pyruvate kinase PEP + ADP + H → PYR + ATP
PNPase Purine nucleoside phosphorylase INO + Pi ↔ HX + R1P
PRM Phosphoribomutase R1P ↔ R5P
PRPPsyn Phosphoribosyl pyrophosphate synthetase R5P + ATP → PRPP + AMP
RPI Ribose-5-phosphate isomerase RL5P ↔ R5P
TA Transaldolase GA3P + S7P ↔ E4P + F6P
TK1 Transketolase X5P + R5P ↔ S7P + E4P
TK2 Transketolase X5P + E4P ↔ F6P + GA3P
TPI Triose phosphate isomerase DHAP ↔ GA3P
XPI Xylulose-5-phosphate epimerase RL5P ↔ X5PBMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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networks now significantly reconstructed for a number of
organisms, the results presented in this work indicate that
it should now be possible – given that feasible genome-
scale sampling has been demonstrated [29,30] – to realize
the dimensionality and mechanisms of metabolic regula-
tion implicit in the topology of these networks.
Methods
Human red blood cell model
For this work we utilized a previously-constructed kinetic
model [31] and a stoichiometric model [22,24] of the
human red blood cell. The stoichiometric model accounts
for 39 metabolites and 32 internal metabolic reactions,
and also contains 12 primary exchange fluxes and 7 cur-
rency exchange fluxes.
Physiologic steady-state flux distributions
Four steady-state flux distributions were calculated using
an in silico kinetic model [31], as detailed in earlier work
[24], and used to represent physiological states of interest
in the solution space. The first distribution was for an
unstressed state or normal physiological state, corre-
sponding to no metabolic load. The other three corre-
sponded to the primary metabolic demands placed upon
the hRBC based on its physiologic role in the human
body. These demands were for ATP (energy load),
NADPH (oxidative load), and NADH (met-hemoglobin
load). In each case, the load was maximized in the kinetic
model to the highest value possible where the model
could still be solved. Thus, they represented as high a load
as the network could handle. All these states were previ-
ously computed and used in a previous study [24]. These
maximum values were 0.37 mM/h for ATP load (above a
mandatory ~1 mM/hr running of the Na+/K+ pump), 2.5
mM/h for the NADPH load, and 1.7 mM/h for the NADH
load.
Physiologic flux constraints
The null space of the stoichiometric matrix of the hRBC
metabolic network is a (mathematically) unbounded
space. To transform this space into one that is physiologi-
cally relevant, we applied, as before, constraints by
bounding the minimum and maximum fluxes for each
reaction. All irreversible reactions were constrained with a
minimum flux of 0 mM/h and a maximum flux of 2000
mM/h unless experimentally-determined maximum flux
values were available. Such maximum reaction rates were
available for 22 reactions, and have been published previ-
ously [22,32]. Additionally, certain fluxes must have a
minimum, non-zero value in order to sustain the hRBC.
These values were obtained from a previous study on the
hRBC [32,33], and since they are few in number are given
here: DPGase, 0.3 mM/h; ATP production, 1 mM/h;
NADH production, 0.4 mM/h; and NADPH production,
0.05 mM/h.
Hit-and-Run sampling of the solution space
We use a variant of an artificial centering hit-and-run algo-
rithm [34] to sample random flux distributions in the
steady-state solution space of the hRBC. The algorithm is
a random walk algorithm entailing three steps. The first
step is to generate a set of "warmup" points in the solution
space. This generation of warmup points was performed
by slightly reducing the maximum flux and increasing the
minimum flux for all reactions and then calculating a can-
didate flux distribution along a reaction coordinate using
linear programming. Ten thousand such warmup points
were created. The second step of the algorithm is to select
an initial point from one of the "warm up" points gener-
ated. The warm up points were stored in a matrix W and
were used to calculate an approximate center s of the solu-
tion space. The third step calculates the sample points.
Beginning with an initial, randomly selected point xm
from W, a direction vector is constructed by choosing a
randomly selected point y from W and moving along the
direction vector d = y-s from xm resulting in a new point
xm+1. After each such move xm+1 was randomly substituted
into W and the approximate center recalculated. For the
results presented herein, we saved a sample point every
1000 moves in the space. It should be noted that the red
blood cell metabolic network does not have any non-triv-
ial biochemical loops (type III ExPas) [35], and thus the
Table 3: The fractional projection of eigenpathways and PRMs onto one another.
from\onto eigpath1 eigpath2 eigpath3 eigpath4 eigpath5 PRM1 PRM2 PRM3 PRM4 PRM5
eigpath1 0 0.021 0.021 0.126 0.384 0.950 0.107 0.077 0.247 0.054
eigpath2 0.022 0 0.039 0.187 0.300 0.028 0.983 0.016 0.195 0.168
eigpath3 0.025 0.045 0 0.011 0.252 0.212 0.189 0.671 0.899 0.231
eigpath4 0.114 0.165 0.009 0 0.108 0.049 0.029 0.280 0.378 0.763
eigpath5 0.387 0.295 0.214 0.120 0 0.282 0.284 0.430 0.584 0.560
P R M 1 0 . 9 5 7 0 . 0 2 7 0 . 1 8 0 0 . 0 5 5 0 . 2 8 2 00000
P R M 2 0 . 1 0 8 0 . 9 6 6 0 . 1 6 0 0 . 0 3 3 0 . 2 8 4 00000
P R M 3 0 . 0 7 8 0 . 0 1 6 0 . 5 6 9 0 . 3 1 1 0 . 4 3 0 00000
P R M 4 0 . 2 4 8 0 . 1 9 2 0 . 7 6 1 0 . 4 2 1 0 . 5 8 4 00000
P R M 5 0 . 0 5 5 0 . 1 6 5 0 . 1 9 5 0 . 8 4 8 0 . 5 6 0 00000BMC Bioinformatics 2006, 7:132 http://www.biomedcentral.com/1471-2105/7/132
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samples generated do not violate "loop law" thermody-
namic constraints [36,37] that would otherwise need to
be explicitly addressed in sampling [30]. Note that in pre-
vious work [22], it was stated that the hRBC contains 16
Type III ExPas. The computation of ExPas in that work
entailed the decoupling of reversible reactions into for-
ward and backward reactions, and these resulting trivial
loops were the 16 Type III pathways. In this work, revers-
ible reactions were not decoupled, and so trivial Type III
pathways were not an issue. One issue not encountered in
this work which will is important for sampling genome-
scale networks is the issue of non-trivial Type III ExPas
(more than 2 reactions). Since Type III ExPas correspond
to thermodynamically infeasible flux distributions, the
generation of samples from genome-scale systems will
need to be cognizant of this issue. This issue has been
addressed elsewhere and will not be an impediment to
sampling genome-scale metabolic networks [30].
Extreme pathways
The extreme pathways were calculated from the stoichio-
metric matrix of the hRBC using a previously published
algorithm [2]. Vmax values for the reactions in the hRBC
have been previously published [22,32]. Each extreme
pathway was scaled by the most limiting Vmax amongst all
reactions that it contained. All of the extreme pathways
had at least one reaction with an experimentally defined
Vmax.
Angle between vectors
Angles between modes were computed using standard lin-
ear algebra. For two vectors u and v, the angle was com-
puted as Θ = cos-1 (u·v/||u|| ||v||).
Regulatory importance of reactions
The result of applying the SVD to either the matrix of
ExPas or the matrix of uniformly sampled flux distribu-
tions is a set of eigenvectors. Each reaction has a corre-
sponding loading vector, which is the vector of the
reaction's contribution to each of the eigenvectors. Specif-
ically, if vij is the contribution of reaction j to eigenvector
i, and there are m eigenvectors, then the loading vector for
reaction j is lj = (v1j, v2j, ... , vmj). The score for reaction j is
then given by the l2-norm of the loading vector: | lj | = (v1j
2
+ v2j
2 + ... + vmj
2)1/2.
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SVD, singular value decomposition; ExPa, extreme path-
way; PRM, principal regulatory mode
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